Maternal Obesity Complicating Pregnancy Clinical Trial
— WiPOfficial title:
Walking in Pregnancy (WiP) - a Social Networking Physical Activity Intervention for Pregnant Obese Women
| Verified date | October 2017 |
| Source | Sheffield Hallam University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
A physical activity feasibility randomised control trial for pregnant, obese women.
| Status | Completed |
| Enrollment | 40 |
| Est. completion date | July 1, 2017 |
| Est. primary completion date | July 1, 2017 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - pregnant 11-14 weeks gestation - BMI >30kg/m2 - No known risks or complications - Able to walk Exclusion Criteria: - High risk of miscarriage |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Sheffield Hallam University |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Recruitment | Recruitment rate will be calculated by simple descriptive statistics. (number of participants approached vs. number of participants that agree to take part) | 5 weeks | |
| Primary | Compliance | Compliance to the study procedures will be calculated by simple descriptive. statistics | 5 weeks | |
| Primary | Attrition | Drop out rate will be calculated by simple descriptive statistics. | 5 weeks | |
| Primary | Adherence rates | Adherence to Fitbit will be measured daily. | 5 weeks | |
| Secondary | Gestational Weight Gain | Women are recruited at 11-14 weeks gestation and after 5 weeks when they are at 20 weeks gestation the final assessments will be collected. Weight is measured in kilograms. | 5 weeks | |
| Secondary | gestational diabetes status | Outcome of the gestational diabetes mellitus test at 26 weeks gestation. | 26 weeks | |
| Secondary | Pregnancy and Birth outcomes | Preeclampsia ( Percentage figure of patients who developed preeclampsia during birth will be calculated from clinical notes). | 9 months | |
| Secondary | C-section | Mode of Delivery ( Number of participants from each group who have a C-section will be calculated) | 9 months | |
| Secondary | Birth weight | Weight of the baby at birth. This data will be collected from clinical notes. | At delivery ( 9 months roughly) | |
| Secondary | Apgar score | 5 minute Apgar Score. Score data will be collected from clinical notes. | At delivery ( 9 months roughly) |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04991402 -
Obesogenic Origins of Maternal and Child Metabolic Health Involving Dolutegravir
|
||
| Active, not recruiting |
NCT02766426 -
Cytokine and Body Composition's Changes in Overweight/Obese Women
|
N/A |